Home » Topics » Conferences

Conferences
RSS

Progenics identifies novel anti-HIV product

Feb. 4, 1999

Single-dose phase I/II trial results in HIV+ adults given PRO-542 presented

Feb. 4, 1999

Agouron's new anti-HIV compounds profiled at AIDS conference

Feb. 4, 1999

Promising early clinical results presented this week for ABT-378 in combination with ritonavir

Feb. 4, 1999

Combinations of K-12 and other anti-HIV compounds tested in vitro for synergy

Jan. 7, 1999

New antiobesity target a focus of attention at recent Japanese meeting

Jan. 7, 1999

New HIV protease inhibitor JE-2147 with promising preclinical profile

Jan. 5, 1999

S-1153: preclinical and preliminary clinical results presented at AIDS congress

Jan. 5, 1999

NO donor effective in canine ischemic liver injury model

Dec. 30, 1998

FR-167653 proves effective against ischemic liver damage

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...